Article Text

Download PDFPDF
I, Sex Robot: the health implications of the sex robot industry
  1. Chantal Cox-George1,
  2. Susan Bewley2
  1. 1 St George’s University Hospitals NHS Foundation Trust, London, UK
  2. 2 Women’s Health Academic Centre, King’s College London, London, UK
  1. Correspondence to Dr Chantal Cox-George, St George’s University Hospitals NHS Foundation Trust, London SW17 0QT, UK; ccoxgeorge{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


The sex technology industry is already estimated to be worth US$30 billion.1 While sex toys are well-established, sex robots (’sexbots'), anthropomorphic devices created for sexual gratification, are no longer science fiction. Four companies sell adult sexbots priced between US$5000 and US$15 000. They must be distinguished from ’paedobots' – childlike robotic models at present only produced by one company.2 The market appears to be men, and so far only ‘female’ adult sexbots have been created, although one company reports aiming to sell ‘male’ devices later in 2018.3 Sex robots are realistic mannequins with variable ages, appearances and textures, and customisable oral, vaginal and anal openings.

The medical profession needs to be prepared for inevitable questions about the impact of sex robots on health. Apart from free-market profits, the majority of arguments in their favour use ‘harm limitation’ somewhat defensively to convince others that this is one way to protect the vulnerable. Opponents reject the hypothesis that they reduce sexual crimes, and instead raise concerns about the potential for harm by further promoting the pervasive idea that living women too are sex objects that should be constantly available - ‘misogynistic objectification’ - and intensifying existing physical and sexual violence against women and children.

What characterises all discussions of this issue is the paucity of an evidence base. This might falsely reassure clinicians not to concern themselves with changing their current clinical practice. However, an absence of evidence does not excuse the medical profession from discussing and debating the issues, as there will inevitably be consequences for physical, mental and social well-being.


We aim to provide a succinct summary of the arguments for and against the sex robot industry and to assess the potential health implications that may affect both patients and clinicians. To find information about the health consequences of …

View Full Text


  • Contributors CCG is an Academic Foundation Year 2 Doctor at St George’s Hospital in London with interests in sexual and reproductive health. She researched and drafted the article. SB is Professor of Women’s Health at King’s College London. She advised and edited the article. Both authors approved the final version.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement No additional data available.

Linked Articles

  • Highlights from this issue
    British Medical Journal Publishing Group